Intravenous Infusions Plc is one of the leading manufacturers of intravenous infusions in Ghana. The group also develops an activity in the manufacturing and distribution of pharmaceutical products. All net sales are in Ghana.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-08-13	GHS 0.4300	+7.50%	1,416,843
26-08-12	GHS 0.4000	-9.09%	163,252
26-08-11	GHS 0.4400	-16.98%	254,788
26-08-10	GHS 0.5300	0.00%	299,122
26-08-07	GHS 0.5300	-8.62%	335,109

End-of-day quote Ghana S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote Ghana S.E. 2026-08-13			5-day change	1st Jan Change
0.4300 ^GHS	+7.50%		-32.81%	+760.00%

07-30	Intravenous Infusions Plc Reports Earnings Results for the Half Year Ended June 30, 2026	CI
01-29	Intravenous Infusions Plc Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	118M 10.71M 9.29M 8.71M 7.94M 14.94M 1.02B 15.17M 103M 40.02M 512M 40.22M 39.35M 1.71B	P/E 2024	-21.3x	P/E 2025	-2.96x
Enterprise Value	128M 11.6M 10.05M 9.42M 8.59M 16.17M 1.11B 16.43M 111M 43.32M 554M 43.54M 42.6M 1.85B	EV / Sales 2024	0.84x	EV / Sales 2025	2.52x
Free-Float	55.31%	Yield 2024 *	-	Yield 2025	-

07-30	Intravenous Infusions Plc Reports Earnings Results for the Half Year Ended June 30, 2026	CI
01-29	Intravenous Infusions Plc Reports Earnings Results for the Full Year Ended December 31, 2025	CI
25-09-08	Intravenous Infusions Plc Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-07-17	Intravenous Infusions Plc announces Annual dividend, payable on July 18, 2025	CI
25-02-02	Intravenous Infusions Plc Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-07-24	Intravenous Infusions Plc Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-02-15	Intravenous Infusions Plc Reports Earnings Results for the Full Year Ended December 31, 2023	CI
23-02-07	Intravenous Infusions Plc Reports Earnings Results for the Full Year Ended December 31, 2022	CI
22-04-26	Intravenous Infusions Plc Reports Earnings Results for the Full Year Ended December 31, 2021	CI
20-06-16	Intravenous Infusions plc Reports Earnings Results for the Full Year Ended December 31, 2019	CI
18-08-07	Intravenous Infusions plc Reports Unaudited Earnings Results for the Six Months Ended June 30, 2018	CI
18-05-09	Intravenous Infusions Plc announced that it expects to receive GHC 5.94 million in funding	CI
18-05-02	IIL Announces Board Changes	CI

25-08-12	Intravenous Infusions : PR-321 INTRAVENOUS INFUSIONS PLC RESOLUTIONS ADOPTED AT THE ANNUAL GENERAL MEETING (AGM) OF THE COMPANY	PU
25-07-28	Intravenous Infusions : PR-278 INTRAVENOUS INFUSIONS PLC NOTICE OF ANNUAL GENERAL MEETING	PU
25-07-17	Intravenous Infusions : PR-266 INTRAVENOUS INFUSIONS PLC PAYMENT OF APPROVED DIVIDEND FOR 2023	PU
25-04-30	Intravenous Infusions : PR-136 INTRAVENOUS INFUSIONS PLC ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2024.	PU
25-02-04	Intravenous Infusions : PR-035 INTRAVENOUS INFUSIONS PLC UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2024.	PU

Intravenous Infusions Plc Stock

Stocks

IIL

GH0000001258

Pharmaceuticals

Valuation: Intravenous Infusions Plc

Chart: Intravenous Infusions Plc

Latest news : Intravenous Infusions Plc

Press Releases: Intravenous Infusions Plc

Quotes and Performance

Course Extremes

Managers and Directors: Intravenous Infusions Plc

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	+7.50%
1 week	-32.81%
Current month	-48.81%
1 month	+53.57%
3 months	+760.00%
6 months	+760.00%
Current year	+760.00%

1 week	0.4	0.53
1 month	0.33	0.86
Current year	0.05	0.86
1 year	0.05	0.86
3 years	0.04	0.86
5 years	0.04	0.86
10 years	0.03	0.86

Manager	Title	Age	Since
Soalihu M. Moukthar CEO	Chief Executive Officer	-	-
Eugenia Bulley DFI	Director of Finance/CFO	-	-
Kenneth Adza-Awude COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Issac Osei CHM	Chairman	75	1998-12-15
Samuel Agyapong Appenteng BRD	Director/Board Member	67	2009-03-11
Leon K. Appenteng BRD	Director/Board Member	63	1996-05-07

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTRAVENOUS INFUSIONS PLC	+7.50%	-32.81%	+975.00%	+975.00%	9.71M
ELI LILLY AND COMPANY	-0.92%	+1.43%	+83.05%	+128.86%	1,088B
JOHNSON & JOHNSON	+0.47%	+1.98%	+50.26%	+50.75%	629B
ABBVIE INC.	+0.83%	+2.85%	+24.49%	+64.82%	440B
ROCHE HOLDING AG	-0.88%	-0.66%	+45.09%	+36.64%	359B
NOVARTIS AG	-0.37%	-1.15%	+26.89%	+36.31%	291B
ASTRAZENECA PLC	+0.05%	-1.20%	+2.31%	+6.15%	245B
AMGEN INC.	+0.40%	+3.21%	+44.42%	+59.17%	225B
NOVO NORDISK A/S	-0.42%	+1.58%	-8.48%	-51.94%	204B
GILEAD SCIENCES, INC.	+1.67%	+5.56%	+14.98%	+72.68%	168B
Average	+0.83%	-0.40%	+125.80%	+137.84%	364.92B
Weighted average by Cap.	-0.13%	+1.47%	+46.06%	+65.97%

	2024	2025
Net sales	24.94M 2.26M 1.96M 1.84M 1.68M 3.16M 216M 3.21M 21.67M 8.46M 108M 8.5M 8.32M 361M	9.3M 845K 732K 686K 626K 1.18M 80.62M 1.2M 8.08M 3.16M 40.36M 3.17M 3.1M 135M
Net income	-643K -58.37K -50.6K -47.43K -43.25K -81.37K -5.57M -82.68K -558K -218K -2.79M -219K -214K -9.3M	-4.63M -421K -365K -342K -312K -586K -40.14M -596K -4.02M -1.57M -20.09M -1.58M -1.54M -67.02M
Net Debt	7.32M 665K 576K 540K 492K 927K 63.44M 941K 6.36M 2.48M 31.76M 2.5M 2.44M 106M	9.75M 885K 767K 719K 656K 1.23M 84.47M 1.25M 8.47M 3.31M 42.28M 3.32M 3.25M 141M